Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Comparative Study of Protective Action of Exogenous 2-Cys Peroxiredoxins (Prx1 and Prx2) Under Renal Ischemia-Reperfusion Injury

Title: Comparative Study of Protective Action of Exogenous 2-Cys Peroxiredoxins (Prx1 and Prx2) Under Renal Ischemia-Reperfusion Injury
Authors: Mars G. Sharapov; Ruslan G. Goncharov; Gleb I. Filkov; Alexander V. Trofimenko; Valery V. Boyarintsev; Vladimir I. Novoselov
Source: Antioxidants, Vol 9, Iss 680, p 680 (2020)
Publisher Information: MDPI AG
Publication Year: 2020
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: peroxiredoxin; antioxidant activity; ischemia-reperfusion; kidney; oxidative stress; Therapeutics. Pharmacology; RM1-950
Description: The pathogenesis of ischemia-reperfusion (I/R) injuries is based on oxidative stress caused by a sharp increase in the concentration of free radicals, reactive oxygen species (ROS) and secondary products of free radical oxidation of biological macromolecules during reperfusion. Application of exogenous antioxidants lowers the level of ROS in the affected tissues, suppresses or adjusts the course of oxidative stress, thereby substantially reducing the severity of I/R injury. We believe that the use of antioxidant enzymes may be the most promising line of effort since they possess higher efficiency than low molecular weight antioxidants. Among antioxidant enzymes, of great interest are peroxiredoxins (Prx1–6) which reduce a wide range of organic and inorganic peroxide substrates. In an animal model of bilateral I/R injury of kidneys (using histological, biochemical, and molecular biological methods) it was shown that intravenous administration of recombinant typical 2-Cys peroxiredoxins (Prx1 and Prx2) effectively reduces the severity of I/R damage, contributing to the normalization of the structural and functional state of the kidneys and an almost 2-fold increase in the survival of experimental animals. The use of recombinant Prx1 or Prx2 can be an efficient approach for the prevention and treatment of renal I/R injury.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/2076-3921/9/8/680; https://doaj.org/toc/2076-3921; https://doaj.org/article/4356c93f06fc49269fea6c9c0e9d7473
DOI: 10.3390/antiox9080680
Availability: https://doi.org/10.3390/antiox9080680; https://doaj.org/article/4356c93f06fc49269fea6c9c0e9d7473
Accession Number: edsbas.D860EDC3
Database: BASE